Drug-Eluting Stents: Advanced Applications for the by Christopher J. White PDF
By Christopher J. White
The remedy for restenosis has been the Holy Grail of interventional cardiology because the introduction of coronary angioplasty within the past due Seventies. the advance of stents enhanced the sturdiness of angioplasty, yet in-stent restenosis used to be a tremendous challenge for sufferers and the physicians. To bring medications in the community on stents that hinder restenosis is a progressive enhance. Percutaneous revascularization know-how has leaped ahead, dramatically changing medical practices, with what could be the unmarried most vital improve within the heritage of cardiology. There are new supply structures and new medications presently being proven. regardless of the continued development, there has been a necessity to collate in one textual content, info on drug eluting stents for coronary sickness. Chris White and co-workers have prepare a logically equipped textual content that progresses from concept to perform, and addresses pharmacologic, technical and strategic matters as they relate to the location of coronary drug-eluting stents.
Read Online or Download Drug-Eluting Stents: Advanced Applications for the Management of Coronary Disease PDF
Best medicine & health sciences books
This can be a 3-in-1 reference ebook. It supplies an entire clinical dictionary overlaying enormous quantities of phrases and expressions in relation to muscular dystrophy. It additionally offers wide lists of bibliographic citations. eventually, it offers info to clients on the way to replace their wisdom utilizing numerous web assets.
The fitting assessment to your scientific terminology direction greater than forty million scholars have relied on Schaum’s Outlines for his or her specialist wisdom and important solved difficulties. Written by means of well known specialists of their respective fields, Schaum’s Outlines conceal every little thing from math to technological know-how, nursing to language.
Très largement prescrits, les psychotropes sont à l'origine d'une véri desk révolution dans le traitement et l. a. compréhension des pathologie s mentales. Cet ouvrage présente une synthèse des connaissances et des pratiques s ur los angeles psychopharmacologie moderne, en tenant compte des données hexago nales et internationales les plus récentes.
The therapy for restenosis has been the Holy Grail of interventional cardiology because the introduction of coronary angioplasty within the overdue Seventies. the improvement of stents more desirable the sturdiness of angioplasty, yet in-stent restenosis used to be a big challenge for sufferers and the physicians. To convey medicines in the community on stents that hinder restenosis is a innovative enhance.
- Medical Terminology: An Illustrated Guide
- Prescrire les psychotropes
- Design of pulse oximeters
- Non-Hodgkin's Lymphoma - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Medical Terminology Systems
- Medical Terminology Systems
Additional resources for Drug-Eluting Stents: Advanced Applications for the Management of Coronary Disease
Vrolix MC, Legrand VM, Reiber JH et al. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol 2000; 86: 385–89 22. Wohrle J, Al-Khayer E, Grotzinger U et al. Comparison of the heparin coated vs the uncoated JOSTENT® – no influence on restenosis or clinical outcome. Eur Heart J 2001; 22: 1808–16 23. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents. Part I. Circulation 2003; 107: 2274–79 24. Klugherz BD, Llanos G, Lieuallen W et al.
Waksman R, Ajani A, Pichard AD et al. Oral rapamycin to inhibit restenosis after stenting of de-novo coronary lesions. The Oral Rapamune to Inhibit Restenosis (ORBIT) study. J Am Coll Cardiol 2004; 44: 1386–92 25. Rodriguez AE, Rodriguez-Alemparte M, Fernandez-Pereira C et al. Oral rapamycin in patients undergoing coronary stent therapy: final results of the ORAR study (Oral Rapamycin in Argentina). J Am Coll Cardiol 2004; 43: 102A 26. Brara PS, Moussavian M, Grise MA et al. Pilot trial of oral rapamycin for recalcitrant restenosis.
The results of the clinical studies using non-polymer-based paclitaxel delivery have been inconclusive. Cook has sponsored three clinical trials that involved non-polymer-based stents. 7 µg/mm2) with a proprietary method, and were compared with the bare metal stent. A dose-dependent effect of paclitaxel on intimal proliferation was reported, but the clinical events were not different at 1 year. 04 mm in the controls). 0 µg/mm2) (Alan Heldman MD, Johns Hopkins University, unpublished data, 2002).
Drug-Eluting Stents: Advanced Applications for the Management of Coronary Disease by Christopher J. White